3 results match your criteria: "Poriyya Medical Center[Affiliation]"

Provisional stenting for multivessel PCI.

Int J Cardiovasc Intervent

August 2005

Cardiovascular Institute, Poriyya medical center, Tiberias, Israel.

Background: Bare stents reduce acute complications and repeat revascularization following percutaneous coronary intervention (PCI), but are costly and may lead to in-stent restenosis. It remains unclear whether stents should be universally implanted or whether provisional stenting mainly to suboptimal balloon dilatation results is an acceptable approach for multivessel PCI.

Objective: To compare the long-term clinical restenosis and target lesion revascularization (TLR) of stented and non-stented coronary artery lesions in patients who had multivessel PCI.

View Article and Find Full Text PDF

C-type natriuretic peptide (CNP) and endothelin-1 are paracrine peptides with opposing effects on cardiac myocyte contraction and intracellular cGMP production. Elevated levels of both endothelin-1 and CNP are found in patients with congestive heart failure. These factors may be related to positive and negative regulation of cell apoptosis in the failing heart.

View Article and Find Full Text PDF

Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1.

Cardiovasc Drugs Ther

January 2003

Department of Cardiology, Poriyya Medical Center, Tiberias, POB 15208, Israel.

The natriuretic peptides are a group of structurally related but genetically distinct peptides. Four types of natriuretic peptides have been found thus far: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP) and Dendroaspis natriuretic peptide (DNP). ANP and BNP are secreted mainly from the heart and function as hormones with vasodilatory and natriuretic effects.

View Article and Find Full Text PDF